The therapeutic mechanism macrophage inflammatory protein 1 alpha (MIP-1α/CCL3) neutralizing antibody in Clostridium difficile infection in mice.
Clostridium difficile infection (CDI) causes diarrhea and colitis. We aimed at finding a common pathogenic pathway in CDI among humans and mice by comparing toxin-mediated effects in human and mouse colonic tissues. We determined the cytokine secretion of toxin A- and B-treated human and mouse colonic explants using multiplex ELISA. Toxin A and toxin B exposure to fresh human and mouse colonic explants caused different patterns of cytokine secretion. Toxin A induced macrophage inflammatory protein 1 alpha (MIP-1α) secretion in both human and mouse explants. Toxin A reduced chloride anion exchanger SLC26A3 expression in mouse colonic explants and human colonic epithelial cells. C. difficile-infected patients had increased colonic MIP-1α expression and reduced colonic SLC26A3 expression compared to controls. Anti-MIP-1α neutralizing antibody prevented mortality, ameliorated colonic injury, reduced colonic IL-1beta mRNA expression, and restored colonic Slc26a3 expression in C. difficile-infected mice. The anti-MIP-1α neutralizing antibody prevented CDI recurrence. Slc26a3 inhibition augmented colonic IL-1β mRNA expression and abolished the protective effect of anti-MIP-1α neutralizing antibody in C. difficile-infected mice. MIP-1α is a common toxin A-dependent chemokine in human and mouse colon. MIP-1α mediates detrimental effects by reducing Slc26a3 and enhancing IL-1β expression in the colon.